Yukihiko Hiroshima

4.0k total citations
134 papers, 2.8k citations indexed

About

Yukihiko Hiroshima is a scholar working on Biotechnology, Biomedical Engineering and Oncology. According to data from OpenAlex, Yukihiko Hiroshima has authored 134 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Biotechnology, 59 papers in Biomedical Engineering and 45 papers in Oncology. Recurrent topics in Yukihiko Hiroshima's work include Cancer Research and Treatments (77 papers), Nanoplatforms for cancer theranostics (58 papers) and Virus-based gene therapy research (32 papers). Yukihiko Hiroshima is often cited by papers focused on Cancer Research and Treatments (77 papers), Nanoplatforms for cancer theranostics (58 papers) and Virus-based gene therapy research (32 papers). Yukihiko Hiroshima collaborates with scholars based in Japan, United States and South Korea. Yukihiko Hiroshima's co-authors include Robert M. Hoffman, Michael Bouvet, Itaru Endo, Takashi Murakami, Kuniya Tanaka, Shinji Miwa, Shuya Yano, Yong Zhang, Ali Maawy and Fuminari Uehara and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yukihiko Hiroshima

126 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukihiko Hiroshima Japan 30 1.7k 1.5k 923 828 454 134 2.8k
Shuya Yano Japan 30 1.5k 0.9× 1.2k 0.8× 991 1.1× 678 0.8× 290 0.6× 106 2.4k
Sharmeela Kaushal United States 24 626 0.4× 724 0.5× 170 0.2× 488 0.6× 246 0.5× 50 1.6k
Mariko Shimokawa Japan 11 219 0.1× 758 0.5× 289 0.3× 1.8k 2.2× 159 0.4× 16 2.8k
Ai Takano Japan 10 184 0.1× 683 0.4× 312 0.3× 1.6k 2.0× 143 0.3× 10 2.6k
Shoichi Date Japan 7 179 0.1× 625 0.4× 306 0.3× 1.5k 1.8× 136 0.3× 8 2.3k
Syed R. Husain United States 30 376 0.2× 231 0.2× 204 0.2× 772 0.9× 146 0.3× 54 2.5k
Carol H. Miao United States 31 130 0.1× 360 0.2× 1.8k 1.9× 850 1.0× 101 0.2× 83 3.4k
Sandrine Valsesia‐Wittmann France 19 133 0.1× 197 0.1× 407 0.4× 1.5k 1.8× 289 0.6× 24 2.7k
Alena Gros Spain 28 212 0.1× 284 0.2× 939 1.0× 4.3k 5.2× 297 0.7× 54 5.6k
Barbara M. Szczerba Switzerland 15 135 0.1× 472 0.3× 103 0.1× 1.6k 1.9× 326 0.7× 23 2.8k

Countries citing papers authored by Yukihiko Hiroshima

Since Specialization
Citations

This map shows the geographic impact of Yukihiko Hiroshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiko Hiroshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiko Hiroshima more than expected).

Fields of papers citing papers by Yukihiko Hiroshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiko Hiroshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiko Hiroshima. The network helps show where Yukihiko Hiroshima may publish in the future.

Co-authorship network of co-authors of Yukihiko Hiroshima

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiko Hiroshima. A scholar is included among the top collaborators of Yukihiko Hiroshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiko Hiroshima. Yukihiko Hiroshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murakami, Takashi, Ryusei Matsuyama, Kentaro Miyake, et al.. (2025). Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer. Anticancer Research. 45(4). 1731–1747.
2.
Okubo, Yoichiro, Rika Kasajima, Shinya Sato, et al.. (2025). Cribriform pattern and IDC ‐P in prostate biopsies: prognostic relevance and reporting in metastatic disease. The Journal of Pathology Clinical Research. 11(6). e70052–e70052.
3.
Washimi, Kota, Yukihiko Hiroshima, Shinya Sato, et al.. (2024). Evaluation of pancreatic cancer specimens for comprehensive genomic profiling. Pathology International. 74(5). 252–261. 3 indexed citations
4.
Washimi, Kota, Yukihiko Hiroshima, Rika Kasajima, et al.. (2023). Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagnostic Pathology. 18(1). 5–5. 3 indexed citations
5.
Nagashima, Takuya, Takashi Oshima, Yukihiko Hiroshima, et al.. (2020). Clinical Significance of Tumour CD44v and MIST1 Expression in Patients With Non-small-cell Lung Cancer. Anticancer Research. 40(11). 6407–6416. 2 indexed citations
6.
Hiroshima, Yukihiko, Rintaro Mori, Yusuke Saigusa, et al.. (2019). MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients. Annals of Surgical Oncology. 26(13). 4506–4514. 10 indexed citations
7.
Hiroshima, Yukihiko, Rika Kasajima, Yayoi Kimura, et al.. (2019). Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters. 469. 217–227. 18 indexed citations
8.
Igarashi, Kentaro, Kei Kawaguchi, Takashi Murakami, et al.. (2019). Patient-derived orthotopic xenograft models of sarcoma. Cancer Letters. 469. 332–339. 19 indexed citations
9.
Miyake, Kentaro, Tasuku Kiyuna, Masuyo Miyake, et al.. (2019). Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model. Biochemical and Biophysical Research Communications. 509(4). 1041–1046. 13 indexed citations
10.
Miyake, Kentaro, Tasuku Kiyuna, Kei Kawaguchi, et al.. (2019). Regorafenib regressed a doxorubicin-resistant Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model. Cancer Chemotherapy and Pharmacology. 83(5). 809–815. 18 indexed citations
11.
Sato, Kei, Rintaro Mori, Yukihiko Hiroshima, et al.. (2018). RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence. Journal of Surgical Research. 226. 122–130. 7 indexed citations
12.
Hiroshima, Yukihiko, Kenichi Matsuo, Takashi Murakami, et al.. (2017). Impact of associating liver partition and portal vein occlusion for staged hepatectomy on tumor growth in a mouse model of liver metastasis. European Journal of Surgical Oncology. 44(1). 130–138. 4 indexed citations
13.
Hiroshima, Yukihiko, Kenichi Matsuo, Daisuke Kawaguchi, et al.. (2016). A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma. Annals of Surgical Oncology. 23(11). 3727–3735. 28 indexed citations
14.
Yamamoto, Mako, Ming Zhao, Yukihiko Hiroshima, et al.. (2016). Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model. PLoS ONE. 11(8). e0160882–e0160882. 80 indexed citations
15.
Hiroshima, Yukihiko, Ali Maawy, Cristina Metildi, et al.. (2014). Successful Fluorescence-Guided Surgery on Human Colon Cancer Patient-Derived Orthotopic Xenograft Mouse Models Using a Fluorophore-Conjugated Anti-CEA Antibody and a Portable Imaging System. Journal of Laparoendoscopic & Advanced Surgical Techniques. 24(4). 241–247. 95 indexed citations
16.
Miwa, Shinji, Yasunori Matsumoto, Yukihiko Hiroshima, et al.. (2014). Fluorescence-guided surgery of prostate cancer bone metastasis. Journal of Surgical Research. 192(1). 124–133. 10 indexed citations
17.
Miwa, Shinji, Shuya Yano, Yukihiko Hiroshima, et al.. (2013). Imaging UVC-induced DNA damage response in models of minimal cancer. Journal of Cellular Biochemistry. 114(11). 2493–2499. 21 indexed citations
18.
Hiroshima, Yukihiko, Ming Zhao, Yong Zhang, et al.. (2013). Comparison of efficacy ofSalmonella typhimuriumA1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle. 12(17). 2774–2780. 72 indexed citations
19.
Hasegawa, Satoshi, et al.. (2009). Parahiatal Hernia Complicated with Gastric Volvulus: Report of a Case. The Japanese Journal of Gastroenterological Surgery. 42(12). 1768–1772. 1 indexed citations
20.
Ishibe, Atsushi, Hideyuki Ike, Yukihiko Hiroshima, et al.. (2007). Perforation of Gastric Ulcer into the Giant Cyst of the Liver: Report of a Case. The Japanese Journal of Gastroenterological Surgery. 40(5). 565–569. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuya Yano Breakdown of academic impact, for papers by Sharmeela Kaushal Breakdown of academic impact, for papers by Mariko Shimokawa Breakdown of academic impact, for papers by Ai Takano Breakdown of academic impact, for papers by Shoichi Date Breakdown of academic impact, for papers by Syed R. Husain Breakdown of academic impact, for papers by Carol H. Miao Breakdown of academic impact, for papers by Sandrine Valsesia‐Wittmann Breakdown of academic impact, for papers by Alena Gros Breakdown of academic impact, for papers by Barbara M. Szczerba
Rankless by CCL
2026